CMPS has benefited from positive phase 3 trial results and positive political developments since my last article. Click here ...
InvestorsHub on MSN
Compass Pathways gains after FDA clears IND for PTSD trial of COMP360
Shares of Compass Pathways Plc (NASDAQ:CMPS) rose about 3% in premarket trading on Wednesday after the company said the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has ...
The company is also advancing commercial preparations for COMP360 in treatment-resistant depression (TRD), aiming to be launch-ready by the end of the year if approved. Compass recently held a ...
Stocktwits on MSN
CMPS stock climbs 5% in premarket after FDA clears PTSD trial path
Compass Pathways (CMPS), on Wednesday, said the U.S. Food and Drug Administration (FDA) has accepted its Investigational New ...
We are fighting for transparency, accountable science, and for the rights of the common people to receive informed consent.
Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.
Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to ...
Alison Brown, a Hartford native who now lives in Nashville, returns to Connecticut at the Katharine Hepburn Cultural Arts ...
Grammy-winning banjoist, composer and label founder Alison Brown returns to the stage next Friday, Nov. 21, with two performances at the Crowninshield Community House. Known for her innovative ...
A proposed $1.6 billion merger would unite the nation's two largest real estate behemoths, Compass and Anywhere, combining Compass's regional brokerages with Anywhere's nationally recognized brands, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results